Yong, Michael
Kirubalingam, Keshinisuthan
Desrosiers, Martin Y.
Kilty, Shaun J.
Thamboo, Andrew
Article History
Received: 31 August 2022
Accepted: 13 July 2023
First Online: 14 October 2023
Declarations
:
: Ethics approval was waived for this study and no consent to participate was needed due to this study’s analysis being based on published literature data.
: All authors consented for publication.
: Dr. Thamboo: Speaker Bureau for Sanofi, GSK, and Stryker; Grant funding from GSK and Sanofi. Dr. Desrosiers: Clinical trial funding from AstraZeneca, GSK, Probionase Therapies, and Sanofi; Advisory boards of Regeneron Pharmaceuticals Inc and Sanofi; Equity in Probionase Therapies. Dr. Kilty: Speaker Bureau for GSK.